Genetic Mechanisms of Immune Evasion in Colorectal Cancer

To understand the genetic drivers of immune recognition and evasion in colorectal cancer, we analyzed 1,211 colorectal cancer primary tumor samples, including 179 classified as microsatellite instability-high (MSI-high). This set includes The Cancer Genome Atlas colorectal cancer cohort of 592 samples, completed and analyzed here. MSI-high, a hypermutated, immunogenic subtype of colorectal cancer, had a high rate of significantly mutated genes in important immune-modulating pathways and in the antigen presentation machinery, including biallelic losses of and genes due to copy-number alterations and copy-neutral loss of heterozygosity. WNT/β-catenin signaling genes were significantly mutated in all colorectal cancer subtypes, and activated WNT/β-catenin signaling was correlated with the absence of T-cell infiltration. This large-scale genomic analysis of colorectal cancer demonstrates that MSI-high cases frequently undergo an immunoediting process that provides them with genetic events allowing immune escape despite high mutational load and frequent lymphocytic infiltration and, furthermore, that colorectal cancer tumors have genetic and methylation events associated with activated WNT signaling and T-cell exclusion. This multi-omic analysis of 1,211 colorectal cancer primary tumors reveals that it should be possible to better monitor resistance in the 15% of cases that respond to immune blockade therapy and also to use WNT signaling inhibitors to reverse immune exclusion in the 85% of cases that currently do not. .

Citing Articles

Coordinated macrophage and T cell interactions mediate response to checkpoint blockade in colorectal cancer.

Mestrallet G, Brown M, Vaninov N, Cho N, Velazquez L, Ananthanarayanan A bioRxiv. 2025; .

PMID: 40027748 PMC: 11870396. DOI: 10.1101/2025.02.12.637954.

Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells.

Singer M, Valerin J, Zhang Z, Zhang Z, Dayyani F, Yaghmai V Cells. 2025; 14(3).

PMID: 39936958 PMC: 11817869. DOI: 10.3390/cells14030166.

The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies.

Wang Q, Yu M, Zhang S Front Immunol. 2025; 15:1440830.

PMID: 39877377 PMC: 11772360. DOI: 10.3389/fimmu.2024.1440830.

Evolutionary trajectories of immune escape across cancers.

Chen W, Baker T, Zhang Z, Ogilvie H, Van Loo P, Gu S bioRxiv. 2025; .

PMID: 39868264 PMC: 11761017. DOI: 10.1101/2025.01.17.632799.

Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma.

Balmaceda N, Kim S Curr Oncol Rep. 2025; 27(2):81-94.

PMID: 39832053 DOI: 10.1007/s11912-024-01624-4.

References

Yin X, Johns S, Kim D, Mikulski Z, Salanga C, Handel T . Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node. J Immunol. 2014; 192(5):2133-42. PMC: 3960083. DOI: 10.4049/jimmunol.1301286. View

Vogel K, Bell L, Galloway A, Ahlfors H, Turner M . The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016; 197(7):2673-2685. PMC: 5027918. DOI: 10.4049/jimmunol.1600854. View

Caldwell G, Jones C, Soon Y, Warrack R, Morton D, Matthews G . Reorganisation of Wnt-response pathways in colorectal tumorigenesis. Br J Cancer. 2008; 98(8):1437-42. PMC: 2361695. DOI: 10.1038/sj.bjc.6604327. View

Langner C . Serrated and non-serrated precursor lesions of colorectal cancer. Dig Dis. 2014; 33(1):28-37. DOI: 10.1159/000366032. View

Meissner T, Li A, Biswas A, Lee K, Liu Y, Bayir E . NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A. 2010; 107(31):13794-9. PMC: 2922274. DOI: 10.1073/pnas.1008684107. View

Hinoue T, Weisenberger D, Lange C, Shen H, Byun H, van den Berg D . Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2011; 22(2):271-82. PMC: 3266034. DOI: 10.1101/gr.117523.110. View

Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F . Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016; 17(1):218. PMC: 5073889. DOI: 10.1186/s13059-016-1070-5. View

Ogino S, Nosho K, Kirkner G, Kawasaki T, Meyerhardt J, Loda M . CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2008; 58(1):90-6. PMC: 2679586. DOI: 10.1136/gut.2008.155473. View

McCrea P, Gottardi C . Beyond β-catenin: prospects for a larger catenin network in the nucleus. Nat Rev Mol Cell Biol. 2015; 17(1):55-64. PMC: 4845654. DOI: 10.1038/nrm.2015.3. View

10.

Basile D, Garattini S, Bonotto M, Ongaro E, Casagrande M, Cattaneo M . Immunotherapy for colorectal cancer: where are we heading?. Expert Opin Biol Ther. 2017; 17(6):709-721. DOI: 10.1080/14712598.2017.1315405. View

11.

Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

12.

Topalian S, Taube J, Anders R, Pardoll D . Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016; 16(5):275-87. PMC: 5381938. DOI: 10.1038/nrc.2016.36. View

13.

Kubo T, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K . Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon. Anticancer Res. 2017; 37(3):1289-1295. DOI: 10.21873/anticanres.11446. View

14.

Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, MaBen S . Genetic evolution of T-cell resistance in the course of melanoma progression. Clin Cancer Res. 2014; 20(24):6593-604. PMC: 8728890. DOI: 10.1158/1078-0432.CCR-14-0567. View

15.

Spranger S, Bao R, Gajewski T . Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature. 2015; 523(7559):231-5. DOI: 10.1038/nature14404. View

16.

Hause R, Pritchard C, Shendure J, Salipante S . Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016; 22(11):1342-1350. DOI: 10.1038/nm.4191. View

17.

Bond C, McKeone D, Kalimutho M, Bettington M, Pearson S, Dumenil T . RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget. 2016; 7(43):70589-70600. PMC: 5342576. DOI: 10.18632/oncotarget.12130. View

18.

Rizvi N, Hellmann M, Snyder A, Kvistborg P, Makarov V, Havel J . Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124-8. PMC: 4993154. DOI: 10.1126/science.aaa1348. View

19.

Peng Y, He Y, Chen C, Xu T, Li L, Ni M . NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Cancer Lett. 2016; 376(1):10-21. DOI: 10.1016/j.canlet.2016.03.006. View

20.

Wang J, Chen Z, Chen H, Wang M, Kong X, Wang Y . Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer. Cell Death Dis. 2014; 5:e1263. PMC: 4047871. DOI: 10.1038/cddis.2014.206. View